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Antidiabetic and antioxidants activities of Clinacanthus nutans (Burm F.) Lindau 
leaves extracts
Abstract
Clinacanthus nutans (Acanthaceae) is a local plant consumed as tisane in Indonesia and ‘ulam’ 
in Malaysia. This plant has been claimed for its ability to prevent many diseases including 
diabetes. However, the scientific proof on this claim is still lacking. Therefore, the present work 
study was designed to evaluate the antidiabetic potential and antioxidant capacity of C. nutans 
leaves extracts using in vitro bioassay tests. The 80% methanolic crude extract of this plant was 
further partitioned using different polarity solvents namely hexane, hexane:ethyl acetate (1:1, 
v/v), ethyl acetate, ethyl acetate:methanol (1:1, v/v), and methanol. All the sub-fractions were 
analysed for antioxidant effect via 2, 2-diphenyl-2-picrylhydrazil (DPPH) scavenging activity, 
ferric reducing power (FRAP) and xanthine oxidase (XO) assays followed by antidiabetic 
evaluation via α-glucosidase and dipeptidyl peptidase-IV (DPP-IV) inhibitory assays and 
glucose uptake experiment. The ethyl acetate fraction showed a good antioxidant potential 
while the hexane fraction exhibited high α-glucosidase and DPP-IV enzyme inhibition. The 
hexane fraction also improved glucose uptake in a dose-dependent manner. The present work 
thus provides an informative data on the potential of C. nutans to be developed as a functional 
food in preventing diabetes.
Introduction
Various plants that have been used or consumed 
for the prevention and treatment of various diseases 
since ancient times are distributed all over Malaysia 
(Bahmani et al., 2014). One of the valuable herbs that 
has undergone multiple research studies in the past 
decades is Clinacanthus nutans (Burm F.) Lindau. 
This medicinal plant is native to several Southeast 
Asian countries including Malaysia (Arullappan 
et al., 2014; Alam et al., 2016). The Indonesians 
prepare decoction or tisane by boiling a handful of 
fresh C. nutans leaves and consume it to prevent 
several illnesses including diabetes (Globinmed, 
2015). In fact, the plant has gained popularity in 
Malaysia and Singapore, where various varieties 
of commercialised products such as teas and drinks 
have been introduced because of its acclaimed 
anticancer properties (Zulkipli et al., 2017). Some 
of the reported pharmacological properties of this 
plant leaves include anticancer, anti-inflammatory, 
antiviral, antidiabetic and antigout (Arullappan et 
al., 2014; Alam et al., 2016). The leaves are typically 
used for the treatment of burns, allergic reactions, 
mucositis, skin rashes and lesions of varicella-
zoster virus (VZV) and herpes simplex virus (HSV) 
(Alam et al., 2016). Several bioactive compounds 
are reported to be present in C. nutans leaves such 
as caffeic acid, chlorogenic acid, quercetin, lupeol, 
betulin, stigmasterol and β-sitosterol (Alam et al., 
2016). 
The present work was aimed to evaluate the 
antidiabetic and antioxidant potentials of the plant 
leaves extract via in vitro bioassays. In vitro bioassay is 
an important analytical method that has high capacity, 
low-cost and provides rapid results that could aid in 
pre-screening, screening, monitoring, and secondary 
testing of natural products (Panuganti, 2015). The 
bioassay tests conducted include 2, 2-diphenyl-2-
picrylhydrazil (DPPH) scavenging activity, ferric 
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reducing power (FRAP) and xanthine oxidase (XO) 
assays followed by antidiabetic evaluation via 
α-glucosidase and dipeptidyl peptidase-4 (DPP-IV) 
inhibitory assays and glucose uptake experiment. 
Materials and methods
Materials
All organic solvents of analytical grade (hexane, 
ethyl acetate, and methanol) and 1, 1-diphenyl-
2-picrylhydrazil (DPPH) reagent were purchased 
from Merck (Darmstadt, Germany). The enzymes, 
α-glucosidase (yeast maltase, Saccharomyces 
cerevisiae) and xanthine oxidase (butter milk) 
were purchased from Megazyme (Ireland) and 
Millipore (USA), respectively. The ρ-nitrophenyl-
ρ-D-glucopyranosidase (PNPG), 2, 4, 6-tripyridyl-
s-triazine (TPTZ), xanthine and quercetin were 
purchased from Sigma Aldrich (St. Louis, MO, USA). 
Allopurinol and glycine were obtained from Nacalai 
Tesque (Kyoto, Japan). The buffer solution was 
prepared using potassium dihydrogen phosphate, and 
dimethoxysulfoxide (DMSO) was used as solvent, 
where both were purchased from HmbG Chemicals 
(Germany).
Sample collection and preparation
Matured leaves of C. nutans were harvested 
from EES Herbs Farm, Penang. The plant sample 
was submitted to the Herbarium, IIUM for species 
authentication. The specimen’s voucher number is 
PIIUM 0238-1. The leaves were dried under shade at 
room temperature (±25°C) for 1 w. The dried leaves 
were then grounded to powder by using Universal 
cutting mill (Fritsch, Germany; Abdul et al., 2011). 
Powdered leaves of C. nutans of about 6 kg were 
subjected to extraction using maceration technique 
with 80% methanol (Yi and Wetzstein, 2011). The 
powdered leaves were macerated into the solution at 
the ratio of 1:3 w/v where the solvent was changed 
each consecutive day. The extracts were filtered and 
recovered using a rotary evaporator at 40°C before 
freeze-drying to remove any remaining solvents. The 
concentrated extracts were then stored at -80°C for 
further analysis (Alothman et al., 2009; Abdul et al., 
2011).
The dried crude extract obtained were subjected 
to further partitioning using 1:3 (w/v) of hexane (H), 
hexane:ethyl acetate (H:E), ethyl acetate (E), ethyl 
acetate:methanol (E:M) and methanol (M) (1:1 v/v). 
The fractions were filtered using Whatman filter paper 
No. 1 and were recovered using a rotary evaporator 
at 40°C before freeze-dried to remove any remaining 
solvents. The fractions were prepared in six replicates 
and stored at -80°C for further analysis (Alothman et 
al., 2009). The yield of extractions was determined in 
the percentage of 100 g ground sample on dry weight 
basis as described by Javadi et al. (2014):
Percentage yield (%) = Mass of extract (g) / Mass of 
     dry sample (g) × 100
In-vitro bioactivity assays 
2, 2-diphenyl-2-picrylhydrazil (DPPH) radical 
scavenging activity
The antioxidant activity using DPPH scavenging 
assay was carried out following the modified method 
described by Pieroni et al. (2002). Accurately, 1 
mg extract was dissolved in 1 mL methanol. About 
20 µL sample solution was treated with 80 µL 0.1 
mM DPPH solution prepared in methanol as well. A 
sample solution of 100 µL was used as blank, and 
ascorbic acid as the positive control to validate the 
assay. The absorbance was measured at 517 nm after 
10 min using spectrophotometer (Tecan Nanoquant 
Infinite M200, Switzerland). The half-maximal 
inhibition concentration (IC50) value was determined. 
Inhibition (%) = [(A0 – A1)/ A0] × 100
where A0 and A1 corresponds to the absorbance 
at 517 nm of the radical (DPP+) in the absence and 
presence of antioxidant respectively.
Ferric reducing power (FRAP)
A modified method described by Ghasemzadeh 
et al. (2015) was adopted for the FRAP assay. The 
FRAP reagent was prepared freshly by mixing 25 
mL acetate buffer (0.1 M), 2.5 mL TPTZ (10 mM) 
and 2.5 mL FeCl3 (20 mM) solutions, and allowed 
to stand for 10 min at 37°C. Plant fractions (20 μL) 
were reacted with FRAP solution (40 μL) for 20 min 
in the dark. The absorbance was measured at 593 nm. 
The antioxidant activity was expressed as ascorbic 
acid equivalent (mg AAE/g extract), which served as 
positive control, using the standard calibration curve 
developed.
Xanthine oxidase inhibition activity
Xanthine oxidase (XO) inhibitory activity was 
measured under an aerobic condition (Gliozzi et 
al., 2016). Samples (2 mg) were dissolved in 1 mL 
5% dimethyl sulfoxide (DMSO) in 50 mM buffer. 
Allopurinol (100 µg/mL), a known XO inhibitor, 
was used as positive control. The reaction mixture 
contained 50mM phosphate buffer (pH 7.5), 0.15 
mM xanthine and 0.3 U/mL of xanthine oxidase from 
buttermilk. The absorption increment was measured 
at 295 nm. All determinations were done in triplicates, 
and percentage of inhibition was determined. XO 
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inhibition activity was expressed as the percentage 
inhibition of XO as follows:
Inhibition (%) = {(A-B) - (C-D)}/ (A-B) × 100
where A was absorbance of the negative control 
(5% DMSO in 50 mM buffer), B was the blank of 
A which was without the enzyme, C was the sample 
with enzyme, and D was the blank of the extract 
without enzyme.
α-glucosidase inhibition (AGI) activity
The α-glucosidase inhibitory activity assay 
was performed based on the protocol mentioned 
by Javadi et al. (2014) which mimics the condition 
of intestinal fluid. All samples and quercetin 
(positive control) were prepared in methanol and 
ρ-nitrophenyl-ρ-D-glucopyranosidase (PNPG, 
substrate) was prepared in 50 mM phosphate buffer 
(pH 6.5). Accurately, 10 µL samples, quercetin, and 
negative control (solvent) each in 100 µL phosphate 
buffer (30 mM) were incubated for 5 min with 
15 µL 0.02 U/µL α-glucosidase enzyme at room 
temperature. Meanwhile, the blank consisted of 115 
µL buffer without the enzyme. All mixtures were 
then treated with 75 μL substrate. The reaction was 
stopped using glycine (pH 10) after another 15 min 
of incubation. The amount of ρ-nitrophenol released 
from PNPG was measured at 405 nm. The IC50 value 
was determined using linear regression analysis. All 
determination was done in triplicates. The inhibitory 
activity (%) of each extract was calculated using the 
following formula:
Inhibition (%) = [(Acontrol - Asample) / Acontrol] × 100%
where Acontrol was the absorbance of the negative 
control, and Asample is the absorbance of sample 
or positive control. The half-maximal inhibition 
(IC50) value was determined using linear regression 
analysis. 
Dipeptidyl peptidase-IV (DPP-IV) Inhibitory Assay
Dipeptidyl peptidase-IV inhibitory activity 
was measured using a commercially available kit 
(Cayman Chemical Company, Ann Arbor, MI, USA) 
according to the supplier's recommendation. In brief, 
samples (30 μL diluted in assay buffer), 10 μL diluted 
DPP-IV, and 10 μL sample were added to each well, 
followed by incubation with 50 μL substrate for 30 
min at 37°C. Then the fluorescence intensity was 
measured at 450-465 nm, with an excitation at 350-
360 nm. DPP-IV inhibitory activity was calculated 
using the following equation:
Inhibition (%) = [(Initial Activity - Inhibitor)/ Initial  
        Activity] × 100 %
where initial activity was the fluorescence of 
negative control and inhibitor was the fluorescence 
of the sample. The result was expressed as IC50 value. 
All determination was done in triplicates.
2-NBDG Uptake in 3T3-L1 Cells Assay
Another mechanism involved in type 2 diabetes 
mellitus includes glucose uptake by adipocytes via 
stimulation of the extract in the presence and absence 
of insulin in the system. 
Cell culture
The 3T3-L1 cells were kindly provided by the 
Integrated Centre for Research Animal Care and 
Use (ICRACU) IIUM that was purchased from the 
American Type Culture Collection, ATCC (Virginia, 
USA). The cells were cultured in complete Dulbecco’s 
Modified Eagle Media (DMEM) containing 10% 
foetal bovine serum (FBS) and 1% penicillin–
streptomycin (Pen-Strep), maintained at 37°C in 
a humidified atmosphere with 5% CO2, and sub-
cultured every three to four days at approximately 
70% confluence (Roffey et al., 2007). 
Cell viability assay
The cell viability assessed using 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay was carried out with the 
method described by Roffey et al. (2007). The 3T3-
L1 cells were seeded into 96-well plate at a density 
of 2.0 × 105 cells/mL and grown until confluence. 
Treatment with C. nutans leaves hexane fraction 
dissolved in DMSO was proceeded for 48 h. At the 
end of the treatment period, cells were washed with 
phosphate buffer saline (PBS) and incubated with 20 
µL MTT solution (5 mg/mL) for 4 h at 37°C. Next, 
100 µL DMSO was added to each well to stop the 
MTT reaction and solubilise the purple formazan 
crystal. After 1 h, spectrophotometric absorbance (A) 
was measured at 570 nm with a reference wavelength 
of 630 nm. The absorbance reading correlated with 
viable cell number and metabolic activity of the cells 
(Roffey et al., 2007). Cell viability (%) was calculated 
using the following equation:
Cell viability (%) = [(A sample - A blank) /  
   A control] × 100 %
where A sample was absorbance of the sample, A 
blank was absorbance of the blank, and A control was 
absorbance of the negative control. 
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3T3-L1 Preadipocyte Differentiation
Preadipocyte differentiation assay was assessed 
following the modified method of Manaharan et 
al. (2013). Firstly, 3T3-L1 pre-adipocytes were 
plated into 96-well plate at approximately 3 × 104 
cells per well. The cells were incubated until 90% 
confluence and maintained in DMEM supplemented 
with 10% FBS, 1% penicillin and 1% hepes buffer at 
37°C under a humidified 5% CO2 atmosphere. The 
initiation of the cell differentiation from preadipocyte 
into adipocytes, occurred at two days after 90% 
confluence (defined as day 0), whereby the cells 
were incubated in differentiation initiation medium 
(DIM) containing 0.5 mM IBMX and 0.25 mM DEX 
in DMEM containing 10% FBS. After two days 
(defined as day 3), the culture media was changed 
to the differentiation progression medium (DPM) 
containing 100 nM insulin and 10% FBS in DMEM. 
At the next two days (defined as day 5), the medium 
was replaced again with fresh DMEM with/without 
insulin (100 nM), and the replacement of fresh 
medium every two days were continued until day 
10. The effects of samples in 3T3-L1 pre-adipocyte 
differentiation were determined by treating the cells 
(from day 0) with hexane fraction of C. nutans leaves 
(0.04–5 µg/mL) for the entire ten days.
The control cultures were treated in basal medium 
(DMEM with 10% FBS and 0.1% DMSO) and 
insulin (100 nM). The cells were also treated with 
rosiglitazone, which served as positive control. The 
concentrations of samples used in this assay were 
determined to be non-cytotoxic to the 3T3-L1 cells, 
as established in the MTT viability assay. The cells 
were then maintained in the original propagation 
DMEM, changing medium every two to three days, 
until use. Plates where cells were >90% differentiated 
were used for experiments between day 9 to 12 post-
induction. Percentage differentiation was observed 
by a visual method. On the day of the experiment, 
each well was examined under the microscope 
to identify the percentage of cells that had not yet 
become adipocytes, which are round and full of 
easily distinguishable fat globules. Wells that were 
used for experimentation contained little to none pre-
adipocyte cells, and were easily distinguishable as 
>90% differentiated overall.
2-NBDG Uptake in 3T3-L1 Cells
The 2-NBDG uptake test in 3T3-L1 cells was 
performed by following the method described by 
Fang et al. (2008) and Saito et al. (2011) with slight 
modifications. Initially, 3T3-L1 cells were cultured 
and differentiated in fluorescent 96-well plate (SPL 
Life Sciences, Korea) and first starved in glucose-
free DMEM for 48 h. Then, glucose uptake was 
initialised by replacing the medium with serum and 
glucose-free DMEM containing 80 µM of 2-NBDG 
fluorescent glucose analogue added with varying 
extract (Hfr) concentrations with/without insulin (100 
nM). Basal medium (DMEM with 10% FBS and 0.1% 
DMSO) and rosiglitazone-treated cells served as the 
control culture and positive control, respectively. 
After 48 h, the culture medium was discarded and 
washed with PBS to remove all traces of 2-NBDG. 
The fluorescence remaining in the cell monolayers 
were quantified with fluorescence microplate reader 
(Perkin Elmer, USA) set at a wavelength of 485 and 
535 nm.
Results
Extraction yield and antioxidant activity (DPPH, 
FRAP and XO)
Table 1 displays the extraction yield, α- 
glucosidase inhibition activity (IC50) and antioxidant 
activity assays (DPPH, FRAP, and XO) of C. nutans 
leaves methanolic extract’s fractions. The result 
showed that the trend of extraction yield followed 
the polarities of the solvents used during extraction. 
The trend of this result was found as Mfr > EMfr > Efr 
> HEfr > Hfr. The most polar fraction, the methanolic 
fraction (Mfr), showed the highest extraction yield 
(64.3%), while the least polar fraction, the hexane 
fraction (Hfr) afforded the least yield (6.6%). Ethyl 
acetate fraction (Efr) exhibited a good activity for all 
the assays with the lowest IC50 value i.e. 37.40 ± 1.45 
µg/mL for the scavenging action, while the rest of 
the fractions had IC50 values of more than 100 µg/
mL, which were comparably higher than that of the 
positive control. As for the FRAP value, the Efr showed 
the highest FRAP activity (79.75±0.17 mg AAE) as 
compared to other fractions with methanolic fraction 
(Mfr) showing the least FRAP activity (57.75 ± 0.86 
mg AAE). However, all fractions of the methanol 
extract showed XO inhibitory activity below 50% 
at 720 µg/mL (assay concentration). Meanwhile, the 
IC50 value of the allopurinol was determined to be 
0.16 ± 0.00 µg/mL. Overall, Efr exhibited promising 
antioxidant activity as compared to the other extracts.
α-glucosidase inhibitory activity
The α-glucosidase inhibitory activity of the C. 
nutans leaves methanol extract’s fractions is displayed 
in Table 1 as the half-maximal concentration values 
(IC50, μg/mL). A lower IC50 value is desirable for 
higher α-glucosidase inhibitory activity (Nsimba 
et al., 2008). The IC50 values ranged from 3.05 to 
133.57 μg/mL. The highest α-glucosidase inhibitory 
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activity was observed for the hexane fraction (3.07 
μg/mL), which was found better as compared to the 
IC50 value obtained for quercetin (positive control). 
Meanwhile, the methanolic fraction exhibited the 
lowest activity with the highest IC50 viz., 133.57 μg/
mL. The fractions exhibited the following trend: Hfr 
> HEfr > EAfr > EAMfr > Mfr (Table 1). As the polarity 
increased, the α-glucosidase inhibitory activity of C. 
nutans leaves decreased significantly.
Table 2 The percentage inhibition for DPP(IV) inhibitory 
assay for C. nutans leaves methanol extract’s hexane 
fraction
Samples Percentage 
inhibition (%)
IC50 (µg/mL)
Sitagliptin 93.92 ± 0.08 0.007
Hexane (Hfr) 91.40 ± 0.18 0.034
Data expressed as mean ± SD. SD = standard deviation.
Dipeptidyl peptidase- IV (DPP-IV) inhibitory 
activity
In order to assess the ability of the hexane extract 
(Hfr) in different mechanism involved in type 2 diabetes 
mellitus, the dipeptidyl peptidase-IV inhibition assay 
was also carried out and the results are presented in 
Table 2 with the percentage of inhibition with IC50 
value also calculated. The hexane fraction of C. nutans 
leaves methanolic extract (which showed the lowest 
IC50 value for α-glucosidase) and sitagliptin (positive 
control) showed comparably good inhibition of the 
dipeptidyl peptidase-IV at 91.40% and 93.92%, 
respectively. The reported IC50 value of sitagliptin is 
0.007 µg/mL (18 nM) according to the value given by 
Cayman, Anbor, USA. Meanwhile, the IC50 value of 
the hexane fraction was calculated as 0.034 µg/mL. 
The result showed that C. nutans leaves methanolic 
extract’s hexane fraction had the capability to inhibit 
the DPP-IV enzyme as well.
2-NBDG Uptake in 3T3-L1 Cells Assay
Cell Viability
Figure 1 shows the cell viability of the positive 
control, rosiglitazone and the C. nutans leaves 
methanolic extract’s hexane fraction. Adipocytes 
are the major target cells of PPARγ-agonists in vitro 
and in vivo, and PPARγ is well demonstrated as a 
major regulator of adipogenesis. Ligand activation 
of PPARγ can promote adipocyte differentiation. 
Thus, we examined the effects of the promising 
extract (leaves methanolic extract’s hexane 
fraction) on adipocyte differentiation. The viability 
of 3T3-L1 cells was determined using the MTT 
method, and results showed no significant toxic 
effects at the concentrations range observed. There 
were no inhibitory effects manifested at different 
concentrations considered. There were no significant 
(p > 0.05) differences in viability of 3T3-L1 cells at 
the concentration of up to 100 µg/mL as compared to 
the control basal (0 µg/mL). Meanwhile, the control 
(rosiglitazone) showed no significant (p > 0.05) 
differences in the viability of 3T3-L1 adipocyte cells 
at a concentration up to 40 µM as compared to the 
control basal (0 µM). 
2-NBDG uptake in 3T3-L1 cells
The ability of C. nutans leaves methanolic 
extract’s hexane fraction to stimulate glucose uptake 
by adipocytes was evaluated on the 2-NBDG uptake 
in terminally differentiated 3T3-L1 adipocytes. 
The hexane fraction stimulated 2-NBDG uptake in 
these cells in a concentration-dependent manner. 
It confirmed insulin-sensitising property of the C. 
nutans leaves methanolic extract’s hexane fraction 
by showing the stimulation of 2-NBDG uptake into 
adipocytes in the presence of insulin. The glucose 
uptake was also stimulated even without the presence 
of insulin, which increased with the concentration of 
Table 1 Extraction yield, α- glucosidase inhibition activity (IC50) and antioxidant activity (DPPH, FRAP and XO) of C. 
nutans leaves methanolic extract’s fractions
Samples Percentage yield (%) AGIIC50 (µg/mL)
DPPH
IC50 (µg/mL)
FRAP
mg AAE /g
XO Percentage 
inhibition (%)
Hexane (Hfr) 6.508 ± 0.324e 3.05 ± 0.05d > 400 72.64 ± 0.28c 12.93 ± 0.33c
Hexane: Ethyl 
acetate (HEfr)
10.074 ± 0.333d 5.54 ± 0.09d 140.98 ± 2.04b 66.48 ± 0.82d 20.61 ± 0.36b
Ethyl acetate (Efr) 12.558 ±0.364c 8.42 ± 0.17c 37.40 ± 1.32c 79.75 ± 0.12a 41.25 ± 0.54a
Ethyl acetate: 
Methanol (EMfr)
23.398 ± 0.707b 37.45 ± 0.90b 328.89 ± 6.33a 77.50 ± 0.67b 9.25 ± 0.21e
Methanol (Mfr) 64.282 ± 0.493a 133.57 ± 0.30a 325.74 ± 1.21a 57.75 ± 0.60e 10.19 ± 0.46d
Quercetin nd 5.77 ± 1.01 nd nd nd
Ascorbic acid nd nd 8.21 ± 0.02d nd nd
Allopurinol nd nd nd nd 91.40 ± 0.00
Data expressed as mean ± SD. SD = standard deviation. 
Means in the same column that do not share the same letter are significantly different with p value < 0.05. nd = not determined. 
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the hexane fraction. This indicated that the leaves 
methanolic extract’s hexane fraction has insulin-like 
activity from the concentration 25 µg/mL to 200 
µg/mL. The result (Figure 2) showed that the plant 
demonstrated its antidiabetic effect (stimulation of 
glucose uptake) far better in the presence of insulin 
than the absence of insulin like a PPARγ agonist, the 
positive control rosiglitazone.
Discussion
Various methods have been developed and 
applied in natural product extraction to prepare plant 
extracts. The most conventional method used since 
decades ago includes boiling or decoction with water, 
which is simple and economically viable. In recent 
times, medicinal plant-based researches have been 
done continuously due to the variety of metabolites 
found in plants with health benefits. In more advanced 
researches nowadays, organic solvents are utilised to 
obtain plant extracts of various metabolites based 
on the polarity and the nature of the compound(s) 
of interest (Zulbadli et al., 2011). Multiple factors 
that might also influence plant extraction procedure 
include the types of solvent used, nature of the plant 
material, temperature and target metabolites (John 
et al., 2006). The variation in the solvent polarity 
results in remarkably different bioactivities and 
phytochemical constituents. Therefore, initially in the 
present work, 80% methanol was used to obtain C. 
nutans leaves methanolic extract’s and subsequently, 
solvents of different polarities were used to obtain 
its different polar and non-polar fractions to evaluate 
the different metabolites that might have different 
polarity thus exhibiting different potentials in the 
bioactivity assay analysis. 
From the results obtained, it can be deduced that 
the plant extract contained polar substances with the 
highest yield furnished by methanolic fraction which 
might include polyhydroxyl compounds as well as 
glycones of different classes of organic compounds 
while the hexane fraction possessed the least yield 
that could possibly contain non-polar compounds 
comprised of fatty acids, terpenoids and pigments 
that have been reported in previous studies (Teshima 
et al., 1997; Sakdarat et al., 2009; Chelyn et al., 2014; 
Tu et al., 2014; Kifayatullah et al., 2015). 
The in vitro antioxidant and antihyperglycaemia 
bioassays were used to screen the bioactivity of C. 
nutans leaves methanolic extract’s different fractions. 
Figure 1 The cell viability of rosiglitazone-treated cells (A) 
and C. nutans leaves methanol extract’s hexane fraction-
treated cells (B). Data presented in mean ± SD. Means that 
do not share a letter are significantly different with p value 
< 0.05. SD = standard deviation.
Figure 2 The 2-NBDG glucose uptake in differentiated 
3T3-L1 cells in the absence (0 nM) and presence (100 
nM) of insulin in positive control rosiglitazone (5–40 µM) 
(A) and at different concentrations of C. nutans leaves 
methanol extract’s hexane fraction (25–200 µg/mL) (B). 
Data presented in mean ± SD. Means that do not share a 
letter are significantly different with p value < 0.001. SD = 
standard deviation.
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Later, the capability of the most active fraction 
inhibiting α-glucosidase activity was further analysed 
for its antidiabetic potential through the inhibition 
of dipeptidyl peptidase-IV (DPP-IV) protein which 
is another therapeutic pathway to treat diabetes. 
Besides, cell viability and 2-NBDG uptake in 3T3-
L1 adipocytes cells were also preliminarily measured 
to assess the insulin sensitising and mimicking effects 
of the resultant hexane fraction (Roffey et al., 2007; 
Choi et al., 2009). 
This finding highlights the radical scavenging 
capacity of the leaves extracts and is consistent with 
the findings previously reported by Sulaiman et al. 
(2015) in which the DPPH activity of C. nutans 
leaves methanolic extract’s ethyl acetate fraction 
showed the highest scavenging activity as compared 
to its hexane fraction which. Besides, Sarega et 
al. (2016) have also reported the poor scavenging 
activity manifested by methanolic and hexane 
fractions with an average scavenging percentage 
of 22% and 18%, respectively. The results of the 
present work however, were found comparable to 
what was reported by Sarega et al. (2016) with 100 
mg GAE/g for ethyl acetate fraction. Other than that, 
the DPPH results were also found comparable to 
what had earlier been reported by Arullappan et al. 
(2014) using ethyl acetate and methanol fractions of 
the aerial part of the plant at 2 mg/mL with 50% and 
37%, respectively. As for the reducing power assay, 
the results were considerably moderate. However, 
Sarega et al. (2016) reported a lower FRAP value for 
hexane fraction (55 mg GAE/g) and a slightly higher 
value for ethyl acetate and methanolic fractions with 
the FRAP value of 100 mg GAE/g and 95 mg GAE/g, 
respectively. The FRAP value for the methanolic 
fraction (57.75 ± 0.86 mg AAE/g) was found 
noticeably higher than that reported by Kong et al. 
(2016) i.e. 10.07 ± 0.01 mg TE/g. Meanwhile, the 
XO inhibitory activity of the plant exhibited a fairly 
low activity with only ethyl acetate fraction showing 
approximately 41% of inhibition. In general, the 
results were found to be contraindicated to what was 
recently reported by Duong et al. (2017) whereby an 
IC50 value of 30.4 µg/mL was observed for the same 
species from Thailand. 
As a matter of fact, variations in results could 
also be manifested due to geographical distribution 
of the plant itself that might influence the presence 
and the quantity of the bioactive compounds in 
the plant material, which might vary depending 
on the different quality of soil, fertiliser and other 
environmental factors (Figueiredo et al., 2007). 
Apart from that, solvent(s) used for the extraction 
of the plant material also plays an important role 
in extracting the bioactive compounds. Differences 
can be observed in terms of yield, composition and 
bioactivity of the extract. Variation in polarities of 
the solvents affects the compounds selectivity, which 
would be more selectively soluble in different solvents 
thus highlighting the importance of investigating and 
identifying the optimal extraction solvent for each 
sample type to evaluate its proper efficacy (Ngo et 
al., 2017).
Furthermore, the α-glucosidase inhibitory 
activity of the fractions decreased with the increase 
in polarity. This indicates the presence of bioactive 
metabolites belonging to the non-polar to semi-polar 
groups such as the terpenoids, sterols and fatty acids 
group members possibly responsible for the above 
results. The result was found agreeable with that 
reported by Lee et al. (2014) which showed weak 
inhibitory activity (13.57%; IC50 value > 1,000 µg/
mL) for the methanolic fraction obtained from the 
C. nutans leaves. The hexane fraction might contain 
terpenoids such as betulin that has previously been 
reported for its α-glucosidase inhibiting potential 
(Raza et al., 2015). Therefore, hexane fraction was 
selected for further investigation.
DPP-IV inhibitors are the most recent incretin 
therapy rapidly developed for the therapeutic use for 
the management of type 2 diabetes mellitus (Elya et 
al., 2015). The result deduced that the hexane fraction 
had a remarkable potential to inhibit DPP-IV enzyme 
as well. This indicates that the phytoconstituents 
in the C. nutans leaves are highly applicable in the 
management of type 2 diabetes mellitus. To our 
knowledge, there is no literature reporting on the 
plants’ antidiabetic activity through this assay.
Apart from this, assessment of the glucose uptake 
by adipocytes via stimulation of the extract (Hfr) in 
the presence and absence of insulin in the system 
along with its cell viability showed the potential of 
the fraction as effective in combating type 2 diabetes 
mellitus. The results showed the ability for the hexane 
fraction to react in the same way as the PPARγ agonist 
by stimulating the glucose uptake even in the absence 
of insulin. However, better results were observed 
with the presence of insulin by exerting insulin-
like activity in a dose dependent manner thus also 
indicating that the constituents present in the hexane 
fraction display synergistic action in this mechanism. 
Phytochemical screening from previous study has 
shown the presence of phenolics, tannins, flavonoids, 
diterpenes and phytosterols (Yang et al., 2013). Some 
of the vital compounds found abundantly in C. nutans 
leaves include stigmasterol, lupeol, β- sitosterol, 
betulin along with some C-glycosyl flavones 
which includes vitexin, isovitexin, schaftoside, 
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isomollupentin 7-O-b-glucopyranoside, orientin and 
isoorientin (Khoo et al., 2015; Alam et al., 2016). 
Some of these compounds are known as effective 
antidiabetic and antioxidant agents (Tanruean et al., 
2017). Conclusively, the plant leaves have potential 
to be developed as an ingredient in functional food 
for the management of diabetes and other disorders 
caused by oxidative stress. 
Conclusion
Conclusively, the present work has shown that C. 
nutans leaves extract possesses promising effects to 
be utilised as a potential antidiabetic and antioxidant 
agent via different mechanisms that can lead to type 
2 diabetes mellitus. C. nutans leaves extract might 
contain phytoconstituents that can be further explored 
to be used as essential ingredient in functional food 
in the management of metabolic disorders. The 
plant leaves also have the potential to be utilised in 
pharmaceutical, cosmeceutical and other industries.
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